Overview
No overview information available.
Indication
No indication information available.
Associated Conditions
- Ankle spasticity following a stroke or traumatic brain injury
- Axillary Hyperhidrosis
- Blepharospasm
- Cervical Dystonia
- Equinus Foot Deformity in Children With Cerebral Palsy
- Focal Dystonia
- Hemifacial Spasm
- Upper Limb Spasticity
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| DYSPORT FOR INJECTION 500 u/vial | SIN10954P | INJECTION, POWDER, FOR SOLUTION | 500 U/Vial | 5/31/1999 | |
| XEOMIN® POWDER FOR SOLUTION FOR INJECTION 100 UNITS/VIAL | SIN14585P | INJECTION, POWDER, FOR SOLUTION | 100 LD50 units | 8/12/2014 | |
| XEOMIN® POWDER FOR SOLUTION FOR INJECTION 50 UNITS/VIAL | SIN14586P | INJECTION, POWDER, FOR SOLUTION | 50 LD50 units | 8/12/2014 | |
| DYSPORT FOR INJECTION 300u/vial | SIN15238P | INJECTION, POWDER, FOR SOLUTION | 300u/vial | 5/16/2017 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| DYSPORT clostridium botulinum type A toxin - haemagglutinin complex 500 Ipsen Units powder for injection vial | 74124 | Medicine | A | 6/16/2000 | |
| DYSPORT clostridium botulinum type A toxin - haemagglutinin complex 125 Ipsen Units powder for injection vial | 235282 | Medicine | A | 10/28/2015 | |
| DYSPORT clostridium botulinum type A toxin - haemagglutinin complex 300 Ipsen Units powder for injection vial | 170651 | Medicine | A | 2/10/2011 |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| No Health Canada approvals found for this drug. | |||||
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.